Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Thoratec HeartMate II Pocket Controllers Linked to Four Deaths March 5, 2014 Irvin Jackson Add Your Comments Thoratec has announced that four patients have died and at least five others were injured while trying to switch to a backup controller for their Heartmate II left ventrical assist system (LVAS) by themselves. The company issued a worldwide urgent medical device correction letter on Tuesday, to update labeling and training materials for the HeartMate II LVAS Pocket System Controller in response to the problems. Thoratec notes that of the nine known events, eight happened when patients trained on an older model tried to switch from the main Pocket Controller to a backup. Learn More About Thoratec HeartMate II Lawsuits Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Thoratec HeartMate II Lawsuits Learn More SEE IF YOU QUALIFY FOR COMPENSATION The Thoratec HeartMate II LVAS is a coronary implant given to patients whose hearts are too weak to efficiently pump blood. Former Vice President Dick Cheney is perhaps the most famous recipient, but they have been widely used among individuals with advanced heart disease who are waiting for a heart transplant or are too weak to undergo such a procedure. The controllers monitor the HeartMate II and warn patients if the battery charge is running low. The company released a new version of the pocket controller in August 2012 in Europe, and then in May 2013 in the U.S. The company states that 2,142 patients have received the new controller. Devices affected by the warning include: HeartMate II Implant Kit with Pocket Controller: Catalog Numbers 106015 and 106016 Pocket Controller: Catalog Numbers 106762 and 106017 HeartMate II LVAD Pump and Pocket Controller Kit: Catalog Number 107801 Pocket Controllers that have been removed from packaging: Model Number 105109 The model number can be found on the side of each pocket controller. The company’s warning suggests that patients trained on the older model may be having difficulties switching from the main controller to a backup controller if they are now using the newer model. Thoratec states that it does not believe anything is wrong with the device and has decided not to issue a HeartMate II LVAS Pocket System Controller recall. “Thoratec’s investigations of these reports have not revealed any failures of the devices to meet specifications or deficiencies in quality control procedures,” the company’s letter states. “No product needs to be returned to Thoratec.” It is likely that the FDA will classify the company’s actions as a Class I medical device recall, considering the deaths and injuries, and the announcement of the company’s warning was flagged as a recall when posted on the FDA’s website. A Class I medical device recall designation is reserved for devices that the agency believes have a high probability of causing severe injuries or death. The company advises patients with the pocket controller to immediately contact their doctor for retraining on the use of the device and to receive an updated Patient Handbook. The company also advises doctors who prescribe the system to review the updated labeling and training materials. This is the latest concern surrounding the Thoratec HeartMate II, which has been linked to a potential risk of blood clots in recent months. A study published in November 2013 highlighted a recent increase in the number of blood clot-related problems with the Thoratec HeartMate II that have been seen since March 2011. After examining data from three different hospitals, researchers from Cleveland Clinic were able to identify that over the past few years there has been an increase in the rate of clot formation during the months after the HeartMate II was implanted, confirming what doctors at the hospital suspected based on their own experiences. The manufacturer has denied that any changes were made to the device and indicate that the small study does not accurately portray the device’s performance. In January 2014, a Thoratec HeartMate II class action lawsuit was filed by investors who say the company withheld important information about the safety and efficacy of the device, which has caused the stock price to decline. Tags: Blood Clot, HeartMate, Thoratec Image Credit: | More HeartMate Lawsuit Stories Medtronic HVAD Stroke Risk May Be Higher Than HeartMate3: Study August 19, 2021 Abbott Warns of New Problems With HeartMate 3 Systems December 12, 2019 Heartmate II LVAS Pocket Control Recall Issued Following Deaths, Malfunctions May 25, 2017 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: today) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025) Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: today) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025) Link Between Hair Relaxers and Cancer To Be Examined by Court During “Science Day” (Posted: 4 days ago) A federal judge has called for Science Day presentations to explain to the court the theories and evidence linking hair relaxer to increased cancer risks. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Cancer Lawsuits Continue To Be Filed as Lawyers Prepare First Cases for Trial (06/24/2025)Replacement Hair Relaxer Lawsuit To Be Selected for MDL Bellwether Pool (06/12/2025)Hair Relaxer Lawsuits and Talcum Powder Lawsuits Designated as New Mass Torts in Philadelphia (05/30/2025)
Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: today) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025)
Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: today) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)
Link Between Hair Relaxers and Cancer To Be Examined by Court During “Science Day” (Posted: 4 days ago) A federal judge has called for Science Day presentations to explain to the court the theories and evidence linking hair relaxer to increased cancer risks. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Cancer Lawsuits Continue To Be Filed as Lawyers Prepare First Cases for Trial (06/24/2025)Replacement Hair Relaxer Lawsuit To Be Selected for MDL Bellwether Pool (06/12/2025)Hair Relaxer Lawsuits and Talcum Powder Lawsuits Designated as New Mass Torts in Philadelphia (05/30/2025)